These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1718285)

  • 1. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma.
    de Paulis A; Valentini G; Spadaro G; Lupoli S; Tirri G; Marone G
    Arthritis Rheum; 1991 Oct; 34(10):1289-96. PubMed ID: 1718285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
    Casolaro V; Spadaro G; Marone G
    Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
    Marone G; Giugliano R; Lembo G; Ayala F
    J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human basophil releasability. I. Age-related changes in basophil releasability.
    Marone G; Poto S; di Martino L; Condorelli M
    J Allergy Clin Immunol; 1986 Feb; 77(2):377-83. PubMed ID: 2418093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
    Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
    J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced basophil releasability in subjects infected with human immunodeficiency virus.
    Miadonna A; Leggieri E; Tedeschi A; Lazzarin A; Chianura L; Froldi M; Zanussi C
    Clin Immunol Immunopathol; 1990 Feb; 54(2):237-46. PubMed ID: 1688523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma.
    Gaddy JN; Busse WW
    Am Rev Respir Dis; 1986 Nov; 134(5):969-74. PubMed ID: 3096179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of basophil histamine releasability between atopic and nonatopic asthmatics.
    Son JW; Kim YK; Chung JW; Lee SR; Cho SH; Min KU; Koh YY; Kim YY
    J Korean Med Sci; 1999 Apr; 14(2):153-8. PubMed ID: 10331560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced priming effect of interleukin 3 on IgE mediated basophil histamine release in patients with systemic sclerosis.
    Tedeschi A; Salmaso C; Milazzo N; Miadonna A
    J Rheumatol; 1998 Jul; 25(7):1320-4. PubMed ID: 9676763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on human basophil releasability.
    Marone G; Poto S; Giugliano R; Bonini S
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):103-6. PubMed ID: 2409008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of the inhibitory effect of sodium on basophil histamine release in patients with systemic sclerosis.
    Tedeschi A; Palella M; Milazzo N; Mascagni B; Miadonna A
    Clin Exp Immunol; 1996 Apr; 104(1):97-102. PubMed ID: 8603541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
    Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
    Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables.
    MacGlashan DW
    J Allergy Clin Immunol; 1993 Feb; 91(2):605-15. PubMed ID: 7679683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability.
    Shim JY; Kim BS; Cho SH; Min KU; Hong SJ
    Clin Exp Allergy; 2003 Jan; 33(1):52-7. PubMed ID: 12534549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evaluation of the basophil/IgE system in the cord blood.
    Miadonna A; Tedeschi A; Leggieri E; Motta G; Fabbri C; Froldi M; Agosti M; Lorini M; Marini A; Zanussi C
    Int Arch Allergy Appl Immunol; 1986; 81(3):276-83. PubMed ID: 2429932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics.
    Casolaro V; Galeone D; Giacummo A; Sanduzzi A; Melillo G; Marone G
    Am Rev Respir Dis; 1989 Jun; 139(6):1375-82. PubMed ID: 2471428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionic regulation of human basophil releasability. I. Inhibitory effect of copper.
    Tedeschi A; Arquati M; Lorini M; Milazzo N; Miadonna A
    Agents Actions; 1992 Sep; 37(1-2):16-24. PubMed ID: 1280906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basophil releasability in severely burned patients.
    Bergmann U; König W; Gross-Weege W; Schlüter B; Köller M; Erbs G; Müller FE
    J Trauma; 1990 Nov; 30(11):1372-9. PubMed ID: 1700141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil "releasability" in patients with asthma.
    Findlay SR; Lichtenstein LM
    Am Rev Respir Dis; 1980 Jul; 122(1):53-9. PubMed ID: 6157344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.